Aggrastat (Tirofiban)
Aggrastat is an IV antiplatelet medicine used in the hospital to reduce thrombotic cardiovascular events in non-ST elevation acute coronary syndrome patients, typically used with other antithrombotic therapy as directed by the care team.
We only dispense medications with a valid prescription from a licensed prescriber.
All prescriptions are reviewed and verified before dispensing. Orders may be delayed or declined if prescription details are missing, do not match the patient information on file, appear altered, or are expired. We may also refuse service if we believe an order is intended for resale or redistribution.
What You Receive
- Aggrastat vial(s) in sealed manufacturer packaging
- Personalized prescription instructions based on your prescriber’s directions
- Medication information leaflet provided by the manufacturer
- Itemized invoice detailing your order
- Rx Required
$531.45
Shipping & Delivery
- Shipped from licensed pharmacy partners
- Tracking information is provided once your order ships
Delivery times may vary based on location and prescription verification.
This page is for general information only and is not medical advice. For medical questions, please speak with your prescriber. See Sources & Methodology for how this information is reviewed and referenced.
Aggrastat Key Facts
What Aggrastat is
A glycoprotein IIb/IIIa inhibitor (antiplatelet) given by intravenous infusion.
What it’s used for
Reducing the rate of thrombotic cardiovascular events in patients with NSTE-ACS.
How it works
It blocks platelet GP IIb/IIIa receptors, which reduces platelet aggregation and lowers the risk of clot formation during an acute coronary syndrome evaluation and treatment period.
Aggrastat Safety Overview
Aggrastat increases bleeding risk because it reduces platelet function. The care team monitors closely during infusion and for a period after stopping treatment.
Aggrastat Warnings & Precautions
Urgent review is needed for any signs of serious bleeding or neurologic symptoms.
Do not use Aggrastat if:
- Active internal bleeding
- History of intracranial hemorrhage, intracranial tumor, arteriovenous malformation, or aneurysm
- Ischemic stroke within 30 days or any history of hemorrhagic stroke
- Major surgery or severe physical trauma within the past month
- Severe uncontrolled hypertension
- Thrombocytopenia or bleeding disorder, as clinically determined
Key warnings to know
- Major bleeding can occur, including intracranial bleeding in rare cases
- Bleeding risk is higher with invasive procedures and when used with other antithrombotic medicines
- Platelet counts are monitored because thrombocytopenia can occur
Side Effects and When to Get Help
The main safety concern is bleeding. Smaller bruises can happen, but bleeding that is heavy, persistent, or internal needs urgent care. Get immediate help for severe headache, weakness, confusion, black stools, vomiting blood, or uncontrolled bleeding.
Possible side effects may include:
- Bleeding or bruising at IV or catheter sites
- Thrombocytopenia
- Nausea
Get urgent help right away for
- Severe headache, sudden weakness, trouble speaking, vision changes
- Vomiting blood or material that looks like coffee grounds
- Black or tarry stools, blood in urine
- Bleeding that will not stop
Interactions
Interaction risk is mainly additive bleeding when Aggrastat is combined with other medicines that affect clotting. The hospital team reviews all antiplatelets, anticoagulants, and procedure plans before and during infusion.
Interactions to review with your prescriber may include:
- Aspirin and other antiplatelet drugs because bleeding risk increases
- Heparin, LMWH, warfarin, DOACs because bleeding risk increases
- Thrombolytics because bleeding risk increases
- NSAIDs because they can increase bleeding risk in some patients
Aggrastat Drug Facts
| Category | Details |
|---|---|
| Brand Name | Aggrastat |
| Drug Class | GP IIb/IIIa inhibitor, antiplatelet |
| Indication | Reduce thrombotic cardiovascular events in NSTE-ACS |
| Dosage Forms | IV injection or premixed IV infusion solution (product dependent) |
| Strengths | Concentration varies by presentation, including premixed infusion solutions and vial concentrates (see product labeling) |
| Contraindications | Active bleeding, certain intracranial conditions, recent stroke, recent major surgery or trauma, severe uncontrolled hypertension |
| Key Safety Alerts | Major bleeding risk and thrombocytopenia risk, requires monitoring |
| Administration Timing | Hospital-administered IV dosing with bolus and continuous infusion protocols as ordered |
| Monitoring | Clinical bleeding checks and platelet counts during therapy |
| Alternatives | Integrilin (eptifibatide), ReoPro (abciximab), P2Y12 inhibitors such as clopidogrel, prasugrel, ticagrelor (choice depends on indication and clinical plan) |
Helpful Information
How To Buy Aggrastat Online
1
Select Your Prescribed Aggrastat Dosage & Strength
Choose the strength and quantity that matches your prescription, then add it to your cart. Orders are limited to a 90-day supply per fill.
2
Complete Checkout
Ensure your shipping and contact information is correct so your order can be processed without delays.
3
Submit Your Aggrastat Prescription
Upload your prescription at checkout. If you need a transfer, provide your prescriber or current pharmacy details and we will request it on your behalf.
Prescription & Dispensing Standards
- Prescription required for all orders and reviewed for pharmacy and regulatory compliance
- Dispensed by licensed pharmacy partners
- Orders are held if information is missing, unclear, or does not match.
- No substitutions without prescriber approval, and no controlled substances.
Our Guarantee
At MyRx Outlet, we are committed to delivering safe, high-quality medications that you can trust. We adhere to strict regulations in every country we operate in, ensuring that your order is handled by a licensed Canadian pharmacy or a trusted partner overseas. Each medication has been legally approved by Health Canada or other respected authorities. To purchase Aggrastat at a discounted rate, call 1-888-551-2467.
FAQs
What is Aggrastat used for?
It is used in NSTE-ACS to reduce thrombotic cardiovascular events during acute hospital management.
Is Aggrastat a blood thinner?
It is an antiplatelet medicine that reduces platelet clumping. It does not work the same way as anticoagulants, but it increases bleeding risk.
What is the main risk?
Bleeding is the main risk, including serious bleeding in some patients.
How is it given?
It is given by IV in a hospital setting using a bolus and infusion protocol as ordered.
What symptoms should be treated as urgent?
Severe headache, sudden weakness, black stools, vomiting blood, blood in urine, or bleeding that will not stop.
Why are other medications reviewed so carefully?
Because combining antiplatelets, anticoagulants, NSAIDs, or thrombolytics can increase bleeding risk.
Ordering & Prescription FAQs
Do I need a prescription?
Yes. It is a prescription medicine and is typically administered under hospital supervision.
How do I submit my prescription?
You can upload it through our Upload Prescription page, email it to info@myrxoutlet.com, or fax it to 1-888-230-1245. If you need a prescription transfer, just let us know at checkout and include your pharmacy or prescriber contact details.
When is my payment processed?
Your payment is processed only after your prescription and order have been reviewed and approved by our licensed pharmacy team. Once everything is confirmed, we’ll process payment and prepare your order for shipping.
What happens if my prescription can’t be verified?
Your order may be placed on hold or declined if prescription details are missing, don’t match, are expired, or can’t be confirmed.
Can you ship to a hospital?
Unfortunately no. We can only ship to residencies.
Sources
FDA Prescribing Information, Aggrastat (tirofiban) label PDF
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020912s027,020913s026lbl.pdf
DailyMed, AGGRASTAT (tirofiban) injection label
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fe0ced75-ccbf-4d2e-bd0d-b57e60ab913f
Health Canada, AGGRASTAT Product Monograph PDF
https://pdf.hres.ca/dpd_pm/00019003.PDF